Contents

Current Pharmacogenomics and Personalized Medicine , Volume 9 - Number 2

Editorial (Moving Beyond Our Mutual Ignorance. Or, How would Engaging the Public Benefit the Personalized Medicine Community?)

, 9(2): 76 - 79

Pascale Lehoux


DOI: 10.2174/187569211795508475




Editorial (Personalised Medicine: Lessons from Birth Defects and Single Gene Disorders)

, 9(2): 80 - 83

Hilary Burton, Luis Nacul and Simon Sanderson


DOI: 10.2174/187569211795508439




Mitogenomics: Recognizing the Significance of Mitochondrial Genomic Variation for Personalized Medicine

, 9(2): 84 - 93

Inigo Martinez-Romero, Sonia Emperador, Laura LLobet, Julio Montoya and Eduardo Ruiz-Pesini


DOI: 10.2174/187569211795508457




Ethical and Policy Considerations in the Application of Pharmacogenomic Testing for Tardive Dyskinesia: Case Study of the Dopamine D3 Receptor

, 9(2): 94 - 101

Michel C.F. Shamy, Clement Zai, Vincenzo S. Basile, James L. Kennedy, Daniel J. Muller and Mario Masellis


DOI: 10.2174/187569211795508448




Pharmacoproteomics Applications for Drug Target Discovery in CNS Disorders

, 9(2): 102 - 122

Seyeon Park


DOI: 10.2174/187569211795508484




Determinants of Treatment Outcomes for Hepatitis C Infection and the Path to Personalized Medicine

, 9(2): 123 - 136

Sanaa M. Kamal


DOI: 10.2174/187569211795508466




Understanding and Applying Personalized Therapeutics at Systems Level:Role for Translational Bioinformatics

, 9(2): 137 - 147

Qing Yan


DOI: 10.2174/187569211795508420




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science